Open AccessSerum level of visfatin can reflect the severity of inflammation in patients with acute cholecystitis
Author(s) -
Jae-Woo Park,
Ok-Hee Kim,
Sang Chul Lee,
Kee-Hwan Kim,
Ha-Eun Hong,
Haeyeon Seo,
Ho Joong Choi,
Say-June Kim
Publication year - 2020
Publication title -
annals of surgical treatment and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.559
H-Index - 25
eISSN - 2288-6796
pISSN - 2288-6575
DOI - 10.4174/astr.2020.99.1.26
Subject(s) - medicine , inflammation , peripheral blood mononuclear cell , tumor necrosis factor alpha , cholecystitis , lipopolysaccharide , intercellular adhesion molecule , interleukin 6 , gallbladder stone , immunohistochemistry , endocrinology , gallbladder , immunology , adhesion , in vitro , cell adhesion , biology , chemistry , biochemistry , organic chemistry
Visfatin is a key cytokine released from the pe ripheral blood mononuclear cells (PBMCs) as well as adipose tissue, and it is involved in immune response as well as inflammation. In this study, we investigated whether the serum visfatin level could be a prognostic factor for predicting the severity of inflammation in patients with acute cholecystitis.